Press Releases Archive
2004
Geneart One of the 10 Most Fascinating Innovations
The Regensburg based biotech company, Geneart GmbH, was honored as one of the winners, in the field of humanity and high-tech, in the „Potential Innovation“ competition sponsored by the German Industrial and Trade Commission (DIHK) and the Financial Times Deutschland (FTD).
read on
EuroVacc successfully completes first clinical phase
The Regensburg based biotech company Geneart GmbH announced the successful completion of the first clinical study of a HIV-vaccination, under the guidance of the European Research Consortium, EuroVacc, at the World Aids Conference in Thailand. This is the first confirmation of a promising development of the first vaccination against the immune deficiency known as AIDS.
read onSi4Health wins the Science4Life Venture Cup 2004
The Regensburg company Si4Health has won the most coveted prize for young, innovative biotechnological companies. Si4Health survived several rounds of judging, against a number of well-known competitors, with their tissue engineering business idea and has received 30,000 Euro along with the esteemed first prize.
read onGerman Founder's Prize for Antisense Pharma
2004 has been the year of awards for the Regensburg Biotech-Company. Following the Bavarian Innovation Prize, Antisense Pharma GmbH received the German Founder’s Prize, for their revolutionary cancer therapy – in the category “Visionary”-, on the 22nd of June in Berlin.
read onWilden establishes Technical Competence Center
Wilden puts up a building for their new Technical Competence Center (TCC) in Wackersdorf, Germany. Once the TCC has been completed, all of the company's technical know-how will be concentrated in this creative think tank. In contrast to the previous technical center, which provided 2,100 sqm of useful area, the new TCC will offer 4,900 sqm for up to 180 employees.
read onARCHIVE